• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

W-54011

CAS No. 405098-33-1

W-54011 ( W54011 | W 54011 | W-54011 )

产品货号. M14391 CAS No. 405098-33-1

一种有效的口服活性非肽 C5a 受体 (CD88;C5aR) 拮抗剂,Ki 为 2.2 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1272 有现货
10MG ¥1920 有现货
25MG ¥3629 有现货
50MG ¥5403 有现货
100MG ¥7687 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    W-54011
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种有效的口服活性非肽 C5a 受体 (CD88;C5aR) 拮抗剂,Ki 为 2.2 nM。
  • 产品描述
    A potent and orally active non-peptide C5a receptor (CD88;C5aR) antagonist with Ki of 2.2 nM; also inhibits C5a-induced intracellular Ca(2+) mobilization, chemotaxis, and generation of reactive super oxide species in human neutrophils with IC50 of 3.1, 2.7, and 1.6 nM, respectively; inhibits C5a-induced neutropenia in gerbils (3-30 mg/kg).
  • 体外实验
    In C5a-induced intracellular Ca2+ mobilization assay with human neutrophils, W-54011 does not show agonistic activity at up to 10 μM and shifts rightward the concentration-response curves to C5a without depressing the maximal responses, indicating that W-54011 is a full antagonist. At concentrations up to 10 μM, W-54011 does not affect Ca2+ mobilization stimulated with sub-maximally effective concentrations of fMLP (1 nM), plateletactivating factor (0.3 nM), and IL-8 (0.1 nM). This result demonstrates that W-54011 is highly specific for C5a receptor.
  • 体内实验
    W-54011 (3-30 mg/kg; oral administration; for 4 hours; male mongolian gerbils) treatment inhibited C5a-induced neutropenia in a dose-dependent manner in gerbils.The species selectivity of W-54011 is examined in rhC5a-induced intracellular Ca2+ mobilization of neutrophils in various species. The W-54011 is able to inhibit the response in cynomolgus monkeys and gerbils with IC50 values of 1.7 nM and 3.2 nM, respectively, but not in mice, rats, guinea pigs, rabbits, and dogs. Animal Model:Male mongolian gerbils (6-12 weeks) injected with rhC5a Dosage:3 mg/kg, 10 mg/kg, 30 mg/kg Administration:Oral administration; for 4 hours Result:Inhibited C5a-induced neutropenia in a dose-dependent manner.
  • 同义词
    W54011 | W 54011 | W-54011
  • 通路
    Immunology/Inflammation
  • 靶点
    Complement System
  • 受体
    Complement System
  • 研究领域
    Other Indications
  • 适应症
    ——

化学信息

  • CAS Number
    405098-33-1
  • 分子量
    493.08
  • 分子式
    C30H37ClN2O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: ≥ 28 mg/mL
  • SMILES
    O=C(C1CCCC2=C1C=C(OC)C=C2)N(CC3=CC=C(N(C)C)C=C3)C4=CC=C(C(C)C)C=C4
  • 化学全称
    1-Naphthalenecarboxamide, N-[[4-(dimethylamino)phenyl]methyl]-1,2,3,4-tetrahydro-7-methoxy-N-[4-(1-methylethyl)phenyl]-, hydrochloride (1:1)

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Sumichika H, et al. J Biol Chem. 2002 Dec 20;277(51):49403-7. 2. Kurihara R, et al. Inflamm Res. 2010 Aug;59(8):659-66. 3. Sendler M, et al. Gastroenterology. 2015 Sep;149(3):765-76.e10.
产品手册
关联产品
  • Sutimlimab

    Sutimlimab 是首创的补体蛋白成分 1,s 亚成分 (C1s)抑制剂,可用于冷凝集素综合征的研究。C1s 是一种丝氨酸蛋白酶,可切割 C4 和 C2 以形成 C3 转化酶。

  • BCX-1470 methanesulf...

    一种丝氨酸蛋白酶抑制剂,可抑制因子 D (IC50=96 nM) 和 C1s (IC50=1.6 nM) 的酯解活性。

  • NDT 9513727

    NDT 9513727 是一种有效的、选择性的、口服生物可利用的 C5a 受体反向激动剂,在放射性配体结合测定中 IC50 为 11.6 nM。